Pages that link to "Q39610993"

The following pages link to p73 function is inhibited by tumor-derived p53 mutants in mammalian cells. (Q39610993):

Displaying 50 items.

• Androgen deprivation-induced senescence promotes outgrowth of androgen-refractory prostate cancer cells (Q21132994) (← links)
• p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53 (Q22010134) (← links)
• Physical interaction with Yes-associated protein enhances p73 transcriptional activity (Q24291023) (← links)
• The p53 family member genes are involved in the Notch signal pathway (Q24291822) (← links)
• HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter (Q24292041) (← links)
• p53 family members in myogenic differentiation and rhabdomyosarcoma development (Q24306987) (← links)
• Induction of p57(KIP2) expression by p73beta. (Q24531472) (← links)
• MCG10, a novel p53 target gene that encodes a KH domain RNA-binding protein, is capable of inducing apoptosis and cell cycle arrest in G(2)-M (Q24552865) (← links)
• The transcriptional repressor ZEB regulates p73 expression at the crossroad between proliferation and differentiation (Q24746257) (← links)
• Oncogenic Intra-p53 Family Member Interactions in Human Cancers (Q26749382) (← links)
• Oncogenic MicroRNAs: Key Players in Malignant Transformation (Q26773316) (← links)
• Involvement of p53 in the repair of DNA double strand breaks: multifaceted Roles of p53 in homologous recombination repair (HRR) and non-homologous end joining (NHEJ) (Q27002581) (← links)
• Smoking, p53 mutation, and lung cancer (Q27014977) (← links)
• The role of tumor suppressor p53 in the antioxidant defense and metabolism (Q27027604) (← links)
• The rebel angel: mutant p53 as the driving oncogene in breast cancer (Q27686765) (← links)
• Gain of function of mutant p53: R282W on the peak? (Q28068551) (← links)
• The Regulation of Tumor Suppressor p63 by the Ubiquitin-Proteasome System (Q28078288) (← links)
• A common polymorphism acts as an intragenic modifier of mutant p53 behaviour (Q28118809) (← links)
• Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1 (Q28283017) (← links)
• Transcriptional dysregulation of the p73L / p63 / p51 / p40 / KET gene in human squamous cell carcinomas: expression of Delta Np73L, a novel dominant-negative isoform, and loss of expression of the potential tumour suppressor p51 (Q28364211) (← links)
• Arsenic trioxide reactivates proteasome-dependent degradation of mutant p53 protein in cancer cells in part via enhanced expression of Pirh2 E3 ligase (Q28541801) (← links)
• p73 as a Pharmaceutical Target for Cancer Therapy (Q28611414) (← links)
• Functional interplay between MDM2, p63/p73 and mutant p53 (Q28910323) (← links)
• Live or let die: the cell's response to p53 (Q29547663) (← links)
• Amphiphysin IIb-1, a novel splicing variant of amphiphysin II, regulates p73beta function through protein-protein interactions (Q30167715) (← links)
• Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers. (Q30354662) (← links)
• p63 and p73: old members of a new family (Q30595453) (← links)
• Two p53 tetramers bind one consensus DNA response element (Q30837439) (← links)
• Aquaporin 3, a glycerol and water transporter, is regulated by p73 of the p53 family (Q32078382) (← links)
• Overexpressed TP73 induces apoptosis in medulloblastoma (Q33290650) (← links)
• Kinase activity-independent suppression of p73alpha by AMP-activated kinase alpha (AMPKalpha). (Q33392580) (← links)
• Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia (Q33396594) (← links)
• Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations (Q33593066) (← links)
• p73 competes with p53 and attenuates its response in a human ovarian cancer cell line. (Q33612929) (← links)
• Activation of p73 and induction of Noxa by DNA damage requires NF-kappa B. (Q33694155) (← links)
• The p53 family: same response, different signals? (Q33720564) (← links)
• Interactions of the p53 protein family in cellular stress response in gastrointestinal tumors (Q33725939) (← links)
• p53 C-terminal phosphorylation by CHK1 and CHK2 participates in the regulation of DNA-damage-induced C-terminal acetylation. (Q33734522) (← links)
• p63 and p73 in tumor suppression and promotion (Q33791424) (← links)
• The p53 gene family (Q33807839) (← links)
• Regulation and function of the p53-related proteins: same family, different rules (Q33885465) (← links)
• Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk (Q33905119) (← links)
• MDM2 inhibitor MI-319 in combination with cisplatin is an effective treatment for pancreatic cancer independent of p53 function (Q33930068) (← links)
• p53 associates with and targets Delta Np63 into a protein degradation pathway (Q34106545) (← links)
• Physical interaction of p73 with c-Myc and MM1, a c-Myc-binding protein, and modulation of the p73 function (Q34114100) (← links)
• Synthetic small inhibiting RNAs: efficient tools to inactivate oncogenic mutations and restore p53 pathways. (Q34156507) (← links)
• From p63 to p53 across p73. (Q34164614) (← links)
• P63 and P73: P53 mimics, menaces and more (Q34185768) (← links)
• p63 steps into the limelight: crucial roles in the suppression of tumorigenesis and metastasis (Q34273826) (← links)
• Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter (Q34277205) (← links)